SVP, General Counsel · BeOne Medicines Ltd. · BeOne Medicines Ltd. — Share Option (Right to Buy)
Side
M
Value
—
Shares
2,626
Price
—
Executed
Jan 7, 2026
Disclosed
Jan 9, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 7 executedJan 9, 2026 disclosed
ONC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 9.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
BeOne Medicines Ltd. — Share Option (Right to Buy)
Ticker
ONC
Shares
2,626
Price per share
$0
Execution date (reported)
Jan 7, 2026
Owned after transaction
30.4K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
2
What this establishes
Lee Chan Henry filed this Form 4 reporting a option exercise of ONC on Jan 7, 2026. It became public on Jan 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, General Counsel
Lee Chan Henrycik:0001980648
Issuer
BeOne Medicines Ltd.cik:0001651308
Revision history · 0
No field has changed since this record was first ingested.
